In this online, on-demand educational video, Steven J Greene, MD, and Anu Lala, MD, will discuss the intersection of CKD and heart failure and the role diabetes plays in these diseases, current guidelines for CKD testing in at-risk patients, and...

In generalized myasthenia gravis (gMG), pathogenic antibodies activate the terminal complement cascade at the neuromuscular junction, leading to membrane attack complex–mediated damage of the postsynaptic membrane. Complement C5 inhibition directly blocks this mechanism, addressing a central driver of disease rather...

The neonatal Fc receptor (FcRn) preserves IgG by preventing lysosomal degradation, thereby extending IgG half-life. Inhibition of FcRn enhances the clearance of pathogenic IgG autoantibodies, resulting in rapid and reversible reductions in circulating AChR and MuSK antibodies without causing broad...

This online, on-demand virtual symposium brings together renowned experts in treating major depressive disorder (MDD). In this educational program, these experts discuss managing patients with MDD by reviewing patient scenarios, reflecting on how to handle challenging cases, and integrating relevant...

This educational program for hematologists delivers a practical, evidence-based update on the management of pain and other common complications in patients with sickle cell disease (SCD). The curriculum emphasizes both acute and chronic pain across the lifespan, integrating current guideline...

Research revealing that overexpression of TL1A drives key pathological pathways in inflammatory bowel disease (IBD) has accelerated the development of biologic therapies aimed at inhibiting this ligand. Early studies of investigational anti-TL1A agents—including tulisokibart, afimkibart, and duvakitug—demonstrate encouraging outcomes in...

In this online, on-demand educational video, Gus Alva, MD, DFAPA; and Erin Crown, MHS, PA-C will discuss the utility of oral antipsychotics for the treatment of newly diagnosed and previously treated patients with schizophrenia. The expert faculty will review the...

Recent advances in the treatment of presbyopia have focused on pharmacological agents as a novel therapeutic strategy that offers noninvasive, reversible options capable of enhancing depth of focus without altering the natural lens structure. As new and emerging pharmacological therapies...

This video-based program is designed for health care professionals to explore the utility of nonopioid therapies in managing acute pain through a unique perspective, putting the patient voice front and center. A patient lends their expertise to this program by...

This online, on-demand virtual symposium brings together renowned experts in glaucoma. In this educational program, these experts focus on interventional glaucoma, a more proactive management approach that aims to minimize the challenges associated with topical glaucoma management with the earlier...